Atossa Therapeutics News, Atossa Therapeutics Quote, ATOS Quote

Atossa Therapeutics (NQ:ATOS) Delayed: 2.91 +0.26 (9.81%)

Prev. Close

$2.65

Today 6M 1Y 5Y

Open

$2.59

52 Wk High

$3.64

52 Wk Low

$0.14

Day High

$2.95

Day Low

$2.51

P/E

N/A

EPS

$0.00

Volume

104,522

Friends, Peers and Foes (?): AEXAY, ATO, NB, A1SN34, ASND (more...)

ALERTS | RSS

Oct 9, 2026 08:15 AM Form 8-K ATOSSA THERAPEUTICS, For: Oct 08
Oct 9, 2026 08:01 AM Atossa Therapeutics sets CVR plan tied to potential FDA voucher
Oct 9, 2026 08:00 AM Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation in Potential Priority Review Voucher Value
Sep 29, 2026 08:02 AM Atossa Therapeutics plans CVR tied to rare pediatric voucher
Sep 29, 2026 08:01 AM Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher
Sep 29, 2026 08:00 AM Form 8-K ATOSSA THERAPEUTICS, For: Sep 29
Sep 24, 2026 08:00 AM Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging
Sep 18, 2026 05:00 PM Form 8-K ATOSSA THERAPEUTICS, For: Sep 18
Aug 7, 2026 08:59 AM Atossa Genetics (ATOS) Tops Q2 EPS by 10c
Aug 7, 2026 08:45 AM Form 8-K ATOSSA THERAPEUTICS, For: Aug 07

Entities mentioned with ATOS

View All Entities